Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
作者信息
Schooler N R, Boothe H, Goldberg S C
出版信息
Arch Gen Psychiatry. 1971 Aug;25(2):138-47. doi: 10.1001/archpsyc.1971.01750140042008.
Abstract
摘要
相似文献
1
Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
Arch Gen Psychiatry. 1971 Aug;25(2):138-47. doi: 10.1001/archpsyc.1971.01750140042008.
2
Prediction of improvement in schizophrenia under four phenothiazines.
Arch Gen Psychiatry. 1967 Jan;16(1):107-17. doi: 10.1001/archpsyc.1967.01730190109015.
3
Differences in clinical effects of three phenothiazines in "acute" schizophrenia.
Dis Nerv Syst. 1967 Jun;28(6):369-83.
4
Specific indications for different classes of phenothiazines.
Arch Gen Psychiatry. 1974 Jan;30(1):94-9. doi: 10.1001/archpsyc.1974.01760070072011.
5
Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.
Curr Ther Res Clin Exp. 1970 Dec;12(12):810-8.
6
Schizophrenic subtypes defined by response to drugs and placebo.
Dis Nerv Syst. 1968 May;29(5):Suppl:153-8.
7
Dyskinesia and neuroleptics.
Arch Gen Psychiatry. 1968 Dec;19(6):700-3. doi: 10.1001/archpsyc.1968.01740120060009.
8
Evaluation of butaperazine in chronic schizophrenia.
Clin Pharmacol Ther. 1968 Nov-Dec;9(6):757-64. doi: 10.1002/cpt196896757.
9
Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
J Nerv Ment Dis. 1967 Aug;145(2):158-62. doi: 10.1097/00005053-196708000-00008.
10
Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.
Psychopharmacologia. 1972;24(1):81-98. doi: 10.1007/BF00402906.
引用本文的文献
1
Fluphenazine decanoate (depot) and enanthate for schizophrenia.
Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2.
2
The treatment-resistant patient and the need to stay crazy.
Psychiatr Q. 1984 Spring;56(1):75-82. doi: 10.1007/BF01324635.
Zotero 插件